Logo image
Bioorganometallic compounds with antimalarial targets: Inhibiting hemozoin formation
Journal article   Peer reviewed

Bioorganometallic compounds with antimalarial targets: Inhibiting hemozoin formation

M. Navarro, W. Castro and C. Biot
Organometallics, Vol.31(16), pp.5715-5727
2012
url
Link to Published Version *Subscription may be requiredView

Abstract

About half of the world's population is at risk of malaria, and in tropical countries it remains a major cause of morbidity and death in children. Drug resistance to current established antimalarial drugs such as chloroquine is driving the rise in malaria-attributed deaths. In the mid-1990s, two groups-in France and in Venezuela-probed the potential contribution of organometallic analogues as a means of discovering new antimalarial drugs. In the present review, key topics of organometallic antimalarials are outlined using examples from the literature. The interdisciplinary research environment of bioorganometallics allows researchers to investigate the whole spectrum of the drugs' mechanisms of action. Targeting the digestive vacuole and inhibiting hemozoin formation is believed to be the main mechanism by which these drugs induce parasite death.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.217 Parasitology - Malaria, Toxoplasmosis & Coccidiosis
1.217.59 Malaria
Web Of Science research areas
Chemistry, Inorganic & Nuclear
Chemistry, Organic
ESI research areas
Chemistry
Logo image